Literature DB >> 24612091

Pneumothorax in patients with severe combined immunodeficiency.

Akihiro Hoshino1, Kohsuke Imai, Yusei Ohshima, Motoko Yasutomi, Masashi Kasai, Masaru Terai, Keiko Ishigaki, Tomohiro Morio, Toshio Miyawaki, Hirokazu Kanegane.   

Abstract

BACKGROUND: Most infants with pneumothorax have underlying conditions. Pneumocystis jirovecii pneumonia (PCP) frequently occurs in patients with severe combined immunodeficiency (SCID). The aim of this study was to determine clinical features of PCP-associated pneumothorax in SCID patients.
METHODS: The medical records of four SCID patients with pneumothorax were retrospectively reviewed.
RESULTS: All four patients were diagnosed as having SCID at the time of contracting PCP. All patients received mechanical ventilation because of severe respiratory failure. Only one patient was successfully extubated and was alive following hematopoietic stem cell transplantation (HSCT); of the remaining patients, however, two died of respiratory failure, and one patient died of early HSCT-related complications.
CONCLUSIONS: Pneumothorax associated with PCP can occur in SCID patients, and they may have a poor prognosis. If pneumothorax occurs in infants, both respiratory management and prompt investigation of the underlying conditions are needed, considering the possibility of PCP associated with SCID.
© 2014 Japan Pediatric Society.

Entities:  

Keywords:  Pneumocystis jirovecii; pneumothorax; severe combined immunodeficiency

Mesh:

Year:  2014        PMID: 24612091     DOI: 10.1111/ped.12325

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  3 in total

Review 1.  Conditioning regimens for inborn errors of immunity: current perspectives and future strategies.

Authors:  Akira Nishimura; Satoshi Miyamoto; Kohsuke Imai; Tomohiro Morio
Journal:  Int J Hematol       Date:  2022-06-08       Impact factor: 2.490

2.  Modifying Post-Operative Medical Care after EBV Implant May Reduce Pneumothorax Incidence.

Authors:  Dominik Herzog; Alexander Poellinger; Felix Doellinger; Dirk Schuermann; Bettina Temmesfeld-Wollbrueck; Vera Froeling; Nils F Schreiter; Konrad Neumann; Stefan Hippenstiel; Norbert Suttorp; Ralf-Harto Hubner
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

3.  Elucidation of the Effects of a Current X-SCID Therapy on Intestinal Lymphoid Organogenesis Using an In Vivo Animal Model.

Authors:  Tomonori Nochi; Shunichi Suzuki; Shun Ito; Shotaro Morita; Mutsumi Furukawa; Daiichiro Fuchimoto; Yoji Sasahara; Katsuki Usami; Kanae Niimi; Osamu Itano; Minoru Kitago; Sachiko Matsuda; Ayumi Matsuo; Yoshihisa Suyama; Yoshifumi Sakai; Guoyao Wu; Fuller W Bazer; Kouichi Watanabe; Akira Onishi; Hisashi Aso
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2020-02-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.